Home › Kanser sa Salivary Gland
Pag-aaral pangklinika para sa Kanser sa Salivary Gland na nagre-recruit sa U.S.
15 pag-aaral para sa Kanser sa Salivary Gland ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Nashville, TN5 pag-aaral
- Houston, TX5 pag-aaral
- Boston, MA5 pag-aaral
- New York City, NY4 pag-aaral
- Philadelphia, PA3 pag-aaral
- Dallas, TX3 pag-aaral
- Highlands Ranch, CO3 pag-aaral
Ayos sa estado
- California4 pag-aaral
- Colorado5 pag-aaral
- Florida4 pag-aaral
- Illinois4 pag-aaral
- Kansas3 pag-aaral
- Massachusetts6 pag-aaral
- Minnesota3 pag-aaral
- New Jersey3 pag-aaral
- New Mexico3 pag-aaral
- New York5 pag-aaral
- Ohio4 pag-aaral
- Pennsylvania4 pag-aaral
- Tennessee5 pag-aaral
- Texas6 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT05408845Phase II Trial of Sacituzumab Govitecan in Recurrent and/or Metastatic Secretory Gland Cancers
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 16, 2026 · NCT05884320A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT06695845Integrated Cancer Repository for Cancer Research
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699Oropharynx (OPX) Biomarker Trial
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 22, 2026 · NCT06356272Post-op T-DM1 in HER-2+ Salivary Gland Carcinomas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT04620187Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 6, 2026 · NCT03740256Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers
Nagre-recruitMaagang Phase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ene 26, 2026 · NCT05553782VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Nagre-recruitPhase 1/2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT03556228Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT00898638A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05941507Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Nagre-recruitObservasyonal na pag-aaral
Edad 21 hanggang 90 · Lahat ng kasarian · Na-update Set 22, 2025 · NCT00900419Physiologic MR Imaging of Salivary Gland Tumors
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT04452162A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2025 · NCT06805617Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.